Resapp Health Ltd operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Resapp Health Ltd with three other
pharmaceutical manufacturers in Australasia:
Bod Australia Ltd
sales of 138,020.00 Australian Dollars [US$107,659.74 ]
(45,311.00 Australian Dollars [US$35,343.94 ]
MGC Pharmaceuticals Ltd
(48,230.00 Australian Dollars [US$37,620.85 ]
Resapp Health Ltd reported sales of A$82,633.00 (US$64.46 thousand)
June of 2016.
decrease of 52.4%
versus 2015, when the company's sales were A$173,427.00 .